Timothy K MacLachlan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Timothy K MacLachlan

Showing results (21-30 of 23) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 23 results.

Regulatory Toxicology and Pharmacology : RTP|January 24, 2021

Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules - A survey of industry 2008-2019Timothy K MacLachlan, Shari Price, Joy Cavagnaro, et al.

Nature Reviews. Drug Discovery|February 6, 2024

The Bespoke Gene Therapy Consortium: facilitating development of AAV gene therapies for rare diseasesP J Brooks, Timothy M Miller, Frédéric Revah, et al.

Nature Reviews. Immunology|September 4, 2012

Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trialChristopher Horvath, Laura Andrews, Andreas Baumann, et al.

Pageof 3

Search research articles

Showing results (21-30 of 23) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 23 results.

Regulatory Toxicology and Pharmacology : RTP|January 24, 2021

Classic and evolving approaches to evaluating cross reactivity of mAb and mAb-like molecules - A survey of industry 2008-2019Timothy K MacLachlan, Shari Price, Joy Cavagnaro, et al.

Nature Reviews. Drug Discovery|February 6, 2024

The Bespoke Gene Therapy Consortium: facilitating development of AAV gene therapies for rare diseasesP J Brooks, Timothy M Miller, Frédéric Revah, et al.

Nature Reviews. Immunology|September 4, 2012

Storm forecasting: additional lessons from the CD28 superagonist TGN1412 trialChristopher Horvath, Laura Andrews, Andreas Baumann, et al.

Pageof 3